Pharmaceutical Sciences

Pharmaceutical Sciences Experts

Mike Powell

Pharmaceutical Sciences
Galera Therapeutics Inc.
United States of America


Dr. Powell joined Sofinnova in 1997 and SVP X is his seventh Sofinnova fund. He has 32 years of experience, including 15 years of R&D before entering the venture community. Dr. Powell has been involved in more than 50 clinical programs and is the author of 90 publications and books, including a 1,000-page treatise on vaccine design. Before joining Sofinnova, he was Group Leader of drug delivery at Genentech, as well as Director of Product Development at Cytel. Before this he was Senior Scientist and Project Team Leader at Syntex Research. Dr. Powell received his PhD in Physical Chemistry from the University of Toronto and carried out postdoctoral studies in Bio-organic Chemistry at the University of California as a National Science and Engineering Research Council Scholar.

Research Interest

Host defense mechanisms,LPS effects on neurotransmitters  

Global Experts from United States of America

Global Experts in Subject